V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16626797 | 330006739 | EEI00 | 2720 | null | 1 | 2013-09-09 | ETOPOSIDE | 330003558 | 330003497 | 330006740 |
| 16626798 | 330006739 | EX950 | 1000 | X721 | 1 | 2013-09-09 | FLUOROURACIL | 330003558 | 330003497 | 330006740 |
| 16626799 | 330006739 | EW100 | 8 | null | 2 | 2013-09-26 | STEROID | 330003558 | 330003497 | 330006740 |
| 16626800 | 330006739 | EUH | 125 | X721 | 2 | 2013-09-27 | NOT CHEMO | 330003558 | 330003497 | 330006740 |
| 16626801 | 330006739 | EW100 | 5750 | X724 | 1 | 2013-09-27 | FLUOROURACIL | 330003558 | 330003497 | 330006740 |
| 16626802 | 330006739 | EN710 | 6700 | null | 1 | 2013-09-27 | IFOSFAMIDE | 330003558 | 330003497 | 330006740 |
| 16626803 | 330006739 | ETG | 500 | null | 1 | 2013-09-28 | RITUXIMAB | 330003558 | 330003497 | 330006740 |
| 16626804 | 330006740 | EEI00 | 2 | X729 | 1 | 2015-04-12 | TOPOTECAN | 330003558 | 330003497 | 330006741 |
| 16626805 | 330006740 | EEI00 | 20 | null | 1 | 2015-04-12 | TOPOTECAN | 330003558 | 330003497 | 330006741 |
| 16626806 | 330006741 | E1UZ0 | 81 | null | 1 | 2016-12-09 | IFOSFAMIDE | 330003565 | 330003498 | 330006742 |
| 16626817 | 330006744 | EC4 | 1710 | N/A | 1 | 2016-03-01 | IFOSFAMIDE | 330003572 | 330003501 | 330006745 |
| 16626818 | 330006744 | EEI00 | 200 | null | 1 | 2016-03-01 | NOT CHEMO | 330003572 | 330003501 | 330006745 |
| 16626819 | 330006746 | ECL02 | 1.3 | null | 1 | 2018-02-10 | DOXORUBICIN | 330003582 | 330003503 | 330006747 |
| 16626820 | 330006746 | EEI00 | 3000 | X721 | 1 | 2018-02-10 | PEMBROLIZUMAB | 330003582 | 330003503 | 330006747 |
| 16626821 | 330006746 | EN710 | 400 | null | 1 | 2018-02-10 | VINCRISTINE | 330003582 | 330003503 | 330006747 |
| 16626822 | 330006746 | EK1PP | 200 | null | 1 | 2018-02-10 | DACTINOMYCIN | 330003582 | 330003503 | 330006747 |
| 16626823 | 330006746 | E1UZ0 | 165 | null | 1 | 2018-02-10 | NOT CHEMO | 330003582 | 330003503 | 330006747 |
| 16626824 | 330006746 | EOF | 18 | X724 | 1 | 2018-02-10 | DOXORUBICIN | 330003582 | 330003503 | 330006747 |
| 16626825 | 330006746 | Haqrsvarq | 1100 | null | 1 | 2018-02-10 | FLUOROURACIL | 330003582 | 330003503 | 330006747 |
| 16626826 | 330006746 | EE813 | 130 | X724 | 1 | 2018-02-10 | DOCETAXEL | 330003582 | 330003503 | 330006747 |
| 16626827 | 330006746 | EE801 | 10 | X721 | 2 | 2018-02-10 | NOT CHEMO | 330003582 | 330003503 | 330006747 |
| 16626828 | 330006747 | EK1EN | 110 | null | 1 | 2015-04-23 | METHOTREXATE | 330003585 | 330003504 | 330006748 |
| 16626829 | 330006747 | EE813 | 1.8 | X729 | 1 | 2015-04-23 | DOXORUBICIN | 330003585 | 330003504 | 330006748 |
| 16626830 | 330006747 | EZ102 | 4 | X721 | 1 | 2015-04-23 | FLUDARABINE | 330003585 | 330003504 | 330006748 |
| 16626831 | 330006748 | EE813 | 1 | X721 | 1 | 2013-04-02 | METHOTREXATE | 330003592 | 330003505 | 330006749 |
| 16626832 | 330006748 | EEI00 | 80 | X724 | 1 | 2013-04-02 | IFOSFAMIDE | 330003592 | 330003505 | 330006749 |
| 16626833 | 330006748 | ECL01 | 1.5 | null | 2 | 2013-04-03 | MULTIPLE | 330003592 | 330003505 | 330006749 |
| 16626834 | 330006748 | EUZ | 16 | X729 | null | 2013-04-03 | TRIAL | 330003592 | 330003505 | 330006749 |
| 16626835 | 330006749 | EEI00 | 76 | X724 | 0 | 2013-04-26 | NOT MATCHED | 330003597 | 330003506 | 330006750 |
| 16626836 | 330006750 | EE813 | 56 | X292 | 1 | 2013-07-14 | VINCRISTINE | 330003608 | 330003508 | 330006751 |
| 16626837 | 330006750 | E1UZ0 | 100 | X724 | 1 | 2013-07-14 | DACTINOMYCIN | 330003608 | 330003508 | 330006751 |
| 16626838 | 330006750 | EEI00 | 0.95 | X724 | 1 | 2013-07-15 | TRIAL | 330003608 | 330003508 | 330006751 |
| 16626839 | 330006751 | EEI00 | 152.54 | X721 | 1 | 2016-06-18 | VINCRISTINE | 330003608 | 330003509 | 330006752 |
| 16626840 | 330006751 | E0N03 | 1.6 | null | 1 | 2016-06-18 | IFOSFAMIDE | 330003608 | 330003509 | 330006752 |
| 16626841 | 330006751 | Haqrsvarq | 3840 | X724 | 1 | 2016-06-19 | IFOSFAMIDE | 330003608 | 330003509 | 330006752 |
| 16626842 | 330006752 | ECL01 | 40 | null | 1 | 2016-10-02 | CYCLOPHOSPHAMIDE | 330003608 | 330003509 | 330006753 |
| 16626843 | 330006752 | EEI00 | 2750 | X721 | 1 | 2016-10-02 | NOT CHEMO | 330003608 | 330003509 | 330006753 |
| 16626844 | 330006752 | EEI00 | 1550 | X724 | 1 | 2016-10-03 | CISPLATIN | 330003608 | 330003509 | 330006753 |
| 16626845 | 330006752 | ECL02 | 2040 | X724 | 5 | 2016-10-03 | TOPOTECAN | 330003608 | 330003509 | 330006753 |
| 16626846 | 330006752 | EK1EN | 160 | X721 | 5 | 2016-10-04 | IFOSFAMIDE | 330003608 | 330003509 | 330006753 |
| 16626847 | 330006752 | ED301 | 0 | X724 | null | 2016-10-04 | IFOSFAMIDE | 330003608 | 330003509 | 330006753 |
| 16626848 | 330006752 | ERA20 | 625 | X721 | 2 | 2016-10-04 | NOT CHEMO | 330003608 | 330003509 | 330006753 |
| 16626849 | 330006752 | ERA20 | 148 | X721 | 1 | 2016-10-04 | DOCETAXEL | 330003608 | 330003509 | 330006753 |
| 16626850 | 330006753 | EEI00 | 1.1 | null | 1 | 2015-05-12 | DOXORUBICIN | 330003608 | 330003509 | 330006754 |
| 16626851 | 330006754 | EPH | 0.75 | null | 2 | 2015-06-06 | CYCLOPHOSPHAMIDE | 330003608 | 330003509 | 330006755 |
| 16626852 | 330006754 | EK1EN | 180 | X721 | 1 | 2015-06-06 | FLUDARABINE | 330003608 | 330003509 | 330006755 |
| 16626853 | 330006754 | EEI00 | 1.1 | X722 | 1 | 2015-06-06 | TRIAL | 330003608 | 330003509 | 330006755 |
| 16626854 | 330006754 | EK1PP | 4880 | X729 | 1 | 2015-06-06 | CYCLOPHOSPHAMIDE | 330003608 | 330003509 | 330006755 |
| 16626855 | 330006754 | EOF | 130 | null | 1 | 2015-06-06 | IFOSFAMIDE | 330003608 | 330003509 | 330006755 |
| 16626856 | 330006754 | ED301 | 5100 | X724 | 1 | 2015-06-06 | DOXORUBICIN | 330003608 | 330003509 | 330006755 |